RVTY · Revvity, Inc. · Metrics
$157.00
+6.06 (+4.01%)
At close · Oct 20
Return incl. dividend (before tax)
Market Cap
$16.84B
Shares
111.59M
Volume · Oct 20
1.39M
Avg daily vol (3M)
1.83M
RVTY metrics
115 of 122 screener metrics currently available.
Market overview
2 metricsShare price
$156.01
Market cap
$16.84B
Price action
20 metricsPrice change (1W)
-3.0%
Price change (30D)
+5.1%
Price change (3M)
+41.8%
Price change (6M)
+62.2%
Price change (YTD)
+56.0%
Price change (1Y)
+61.6%
Trailing year
Price change (5Y)
-12.0%
52-week high
$157.36
52-week low
$82.26
Change from 52-week high
-4.1%
Change from 52-week low
+83.5%
Annualized volatility
38.8%
Annualized volatility (3M)
37.6%
Beta
1.2
RSI (14D)
56.1
Price vs SMA 50
+10.3%
Price vs SMA 200
+38.0%
Avg volume (3M)
1.83M
Relative volume
0.7
Average dollar volume
$243.74M
Company
3 metricsSector
Healthcare
Industry
Diagnostics & Research
Shares outstanding
111.59M
Valuation
12 metricsP / E (TTM)
72.2
Trailing earnings · reciprocal yield 1.4%
PEG ratio
33.2
EV / revenue
6.6×
reciprocal yield 15.2%
EV / EBITDA
24.9×
reciprocal yield 4.0%
EV / EBIT
53.5×
reciprocal yield 1.9%
P / sales
5.8×
reciprocal yield 17.1%
P / book
2.4
reciprocal yield 42.4%
FCF yield
3.3%
TTM · current market cap
Buyback yield
2.8%
P / FCF
30.5
reciprocal yield 3.3%
P / operating cash flow
27.1
reciprocal yield 3.7%
Earnings yield
1.4%
Historical valuation
8 metricsP / E historical average (3Y)
42.5×
reciprocal yield 2.4%
P / E historical average (5Y)
34.9×
reciprocal yield 2.9%
EV / revenue historical average (3Y)
5.1×
reciprocal yield 19.7%
EV / revenue historical average (5Y)
5.1×
reciprocal yield 19.5%
EV / EBIT historical average (3Y)
43.6×
reciprocal yield 2.3%
EV / EBIT historical average (5Y)
37.1×
reciprocal yield 2.7%
EV / EBITDA historical average (3Y)
18.9×
reciprocal yield 5.3%
EV / EBITDA historical average (5Y)
17.9×
reciprocal yield 5.6%
Dividends & buybacks
7 metricsDividend yield
0.1%
Trailing 12 months
Payout ratio
13.4%
Shareholder yield
3.0%
Dividend / share (TTM)
$0.21
Dividend growth YoY
-25.0%
Dividend growth streak
0
Last ex-dividend
2026-07-17
Earnings calendar
2 metricsNext earnings
2026-11-03
Last earnings
2026-08-04
Profitability
9 metricsGross margin
—
Operating margin
12.3%
Trailing 12 months
Net margin
8.2%
Gross profit (TTM)
$1.99B
Operating profit (TTM)
$358.85M
Net income (TTM)
$237.55M
Trailing 12 months
Diluted EPS (TTM)
$2.09
FCF margin
19.2%
Effective tax rate
9.0%
Growth
11 metricsRevenue growth YoY
+1.3%
Year over year
Net income growth YoY
-3.9%
Revenue (TTM)
$2.91B
Trailing 12 months
EPS growth YoY
+2.2%
Shares change YoY
-5.0%
Year over year · fewer shares
Revenue CAGR (3Y)
-4.8%
Revenue CAGR (5Y)
-5.5%
EPS CAGR (3Y)
-22.8%
EPS CAGR (5Y)
-20.4%
FCF CAGR (3Y)
-5.0%
FCF CAGR (5Y)
-9.3%
Quality
14 metricsReturn on equity
3.3%
Return on assets
2.0%
Debt / equity
0.4
Current ratio
1.8
EBITDA (TTM)
$771.08M
Free cash flow (TTM)
$558.11M
Quick ratio
1.5
Interest coverage
3.8
Net debt / EBITDA
2.8
Return on invested capital
3.5%
Trailing 12 months
Net cash
−$2.18B
Latest balance sheet
Cash & equivalents
$1.02B
Total assets
$12.05B
Total debt
$3.21B
Cash flow & spend
7 metricsOperating cash flow (TTM)
$627.63M
Capital expenditures (TTM)
$69.52M
R&D (TTM)
$215.83M
SG&A (TTM)
$1.03B
Stock compensation (TTM)
$24.43M
R&D / revenue
7.4%
Stock compensation / revenue
—
Ownership (13F)
9 metrics13F filers
546
13F filer change QoQ
+39
Institutional ownership
102.2%
Conviction holders (share of 13F filers)
0.7%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
-3.8%
Holder tenure
15.2
Price vs estimated holder cost
+9.6%
Ownership (registered funds)
1 metricsIndex-fund ownership
22.1%
Short interest
3 metricsShort interest
5.6%
Latest settlement · 2.4 days to cover
Days to cover
2.4d
Short-squeeze score
60 / 100
Insider activity
2 metricsNet insider buying (90D)
−$1.28M
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
—